ADenoVirus Initiative Study in Epidemiology in Spain
NCT02254330 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 386
Last updated 2017-01-10
Summary
The objectives of this study is to assess the characteristics and frequency of adenovirus conjunctivitis in a population of male and female patients from one year of age who present signs and symptoms of acute conjunctivitis.
Conditions
- Viral Conjunctivitis
Sponsors & Collaborators
-
NicOx
lead INDUSTRY
Principal Investigators
-
Jose Manuel Benitez Del Castillo, MD · Ocumed Clinica Oftalmologica
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-08-31
Countries
- Spain
Study Locations
More Related Trials
-
Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears
NCT00266734 ·Status: COMPLETED ·Phase: NA
-
AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
NCT02161146 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
NCT01532336 ·Status: COMPLETED ·Phase: PHASE2
-
AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis
NCT02082262 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo
NCT02998554 ·Status: TERMINATED ·Phase: PHASE3
-
A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis
NCT02492321 ·Status: COMPLETED ·Phase: PHASE3
-
Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy
NCT07171307 ·Status: NOT_YET_RECRUITING
-
A Multi-Center Study Evaluating the Safety of AC-170 0.24%
NCT02132169 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
NCT00105469 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
NCT05591755 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
NCT01877694 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)
NCT01977443 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis
NCT01089608 ·Status: COMPLETED ·Phase: PHASE2
-
Quality of Life In Patients With Allergic Conjunctivitis In Treatment With Sublingual Allergen Immunotherapy In A Referral Ophthalmological Hospital
NCT07149298 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
NCT02079649 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
NCT02998541 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis
NCT01258309 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
NCT01881113 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
NCT00921895 ·Status: COMPLETED ·Phase: NA
-
Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
NCT01721694 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
NCT00244543 ·Status: COMPLETED ·Phase: PHASE3
-
AL-15469A for the Treatment of Bacterial Conjunctivitis
NCT00331916 ·Status: COMPLETED ·Phase: PHASE3
-
OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis
NCT03856645 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
NCT03162094 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Reducing Adenoviral Patient Infected Days
NCT02472223 ·Status: COMPLETED ·Phase: NA